PHARMACEUTICAL PATENTING IN INDIA: PROBLEM OF PUBLIC ACCESS TO HEALTH
Downloads
Abstract
In India, a large part of the population living below the poverty line, with expenses towards healthcare out of pocket; have been living in a significant health crisis with the inability towards accessibility, affordability and availability of the medicine.
Today, IPR Laws are getting more and more popular. They provide relief to the innovative minds ensuring their inventions, ideas, and discoveries remain theirs. Amongst these laws, patent laws have assumed maximum importance. However, where medicines are concerned, these patent laws act as a blockage to the access of these essential commodities. India has become a pioneer in the developing world with attempts towards adapting pharmaceutical patent law, taking account of the domestic health needs of its citizens thereby facilitating its national development.
The issue of access to medicines has assumed global dimensions since several decades ever since India became a part of the Doha Declaration on the TRIPS Agreement and Public Health, 2001. The recent patent law decisions including that of the Supreme Court in the Novartis case have indicated that India has continued to put a premium on public health in relation to pharmaceutical patent law decisions. This article deals with the meaning of pharmaceutical drugs, the process of its patenting in India, and the problems that and the problems it follows, thereby disabling and making difficult the public access to health.
External References to this Article
Loading reference data...
License Terms
Ownership and Licensing:
Authors of research papers submitted to any journal published by The Law Brigade Publishers retain the copyright of their work while granting the journal specific rights. Authors maintain ownership of the copyright and grant the journal the right of first publication. Simultaneously, authors agree to license their research papers under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) License.
License Permissions:
Under the CC BY-SA 4.0 License, others are permitted to share and adapt the work, even for commercial purposes, provided that appropriate attribution is given to the authors, and acknowledgment is made of the initial publication by The Law Brigade Publishers. This license encourages the broad dissemination and reuse of research papers while ensuring that the original work is properly credited.
Additional Distribution Arrangements:
Authors are free to enter into separate, non-exclusive contractual arrangements for distributing the published version of the work (e.g., posting it to institutional repositories or publishing it in books), provided that the original publication by The Law Brigade Publishers is acknowledged.
Online Posting:
Authors are encouraged to share their work online (e.g., in institutional repositories or on personal websites) both prior to submission and after publication. This practice can facilitate productive exchanges and increase the visibility and citation of the work.
Responsibility and Liability:
Authors are responsible for ensuring that their submitted research papers do not infringe on the copyright, privacy, or other rights of third parties. The Law Brigade Publishers disclaims any liability for any copyright infringement or violation of third-party rights within the submitted research papers.
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright © 2026 by Shereen Samant
The copyright and license terms mentioned on this page take precedence over any other license terms mentioned on the article full text PDF or any other material associated with the article.
